Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3975350
Max Phase: Preclinical
Molecular Formula: C18H11F2NO2
Molecular Weight: 311.29
Molecule Type: Small molecule
Associated Items:
ID: ALA3975350
Max Phase: Preclinical
Molecular Formula: C18H11F2NO2
Molecular Weight: 311.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(c1ccc(F)c(O)c1)c1cccc(-c2ccc(F)cc2)n1
Standard InChI: InChI=1S/C18H11F2NO2/c19-13-7-4-11(5-8-13)15-2-1-3-16(21-15)18(23)12-6-9-14(20)17(22)10-12/h1-10,22H
Standard InChI Key: DJUNBHCDMBSYOQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 311.29 | Molecular Weight (Monoisotopic): 311.0758 | AlogP: 3.96 | #Rotatable Bonds: 3 |
Polar Surface Area: 50.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.76 | CX Basic pKa: 1.88 | CX LogP: 4.62 | CX LogD: 4.46 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.74 | Np Likeness Score: -0.87 |
1. Braun F, Bertoletti N, Möller G, Adamski J, Steinmetzer T, Salah M, Abdelsamie AS, van Koppen CJ, Heine A, Klebe G, Marchais-Oberwinkler S.. (2016) First Structure-Activity Relationship of 17β-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal Inhibitors and Crystal Structures in Complex with the Enzyme., 59 (23): [PMID:27933965] [10.1021/acs.jmedchem.6b01436] |
Source(1):